Hutchison represents numerous leading companies in the biotechnology, biopharmaceuticals, specialty pharmaceuticals, drug discovery, genomics, diagnostics, drug delivery, medical device and healthcare services industries. Our breadth of industry experience and understanding of the unique issues facing life science companies enables us to provide our clients with the sophisticated legal and strategic business advice necessary to succeed in the marketplace.
We work closely with our clients through each stage of their life cycle. Our engagement often begins at the inception of the company, helping entrepreneurs to form new companies based on novel intellectual property and technology. We then assist our clients in capturing and protecting intellectual property through licensing, trademark and other means. Where clients are required to comply with rigid FDA regulations, we can help implement compliance processes.
Building a life sciences company is often a capital intensive endeavor. Therefore, a core competency of our practice involves assisting our clients in raising the outside capital necessary to fund research, development and commercialization. As our clients mature, we have the legal and transactional experience necessary to assist them with exploiting the company's intellectual property assets by structuring and negotiating intellectual property licenses and other commercial partnerships. Additionally, we have helped countless companies to achieve shareholder liquidity through both public offerings and negotiated mergers and acquisitions.
We are also frequently called upon to assist larger U.S. and international companies expand their life sciences businesses through corporate partnerships and acquisitions.